Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
Also Known As
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies1000
MediWound
MediWound is a biopharmaceutical company that develops and commercializes bio-therapeutic solutions for tissue repair and regeneration.
Sector
Subsector
Keywords
Location
total rounds
total raised
BioD, LLC
BioD, LLC is a biotech company that develops and commercializes regenerative medicine products derived from placental tissues.
Sector
Subsector
Keywords
Location
Elanix Biotechnologies
Elanix Biotechnologies is a life sciences company specializing in tissue regeneration products.
Sector
Subsector
Keywords
Location
total rounds
total raised
Akron Biotechnology
Akron Biotechnology is a biotech company that manufactures high-quality products for advanced therapies.
Sector
Subsector
Keywords
Location
M&A Details1
Financials
Funding Rounds3
Number of Funding Rounds
Money Raised
Their latest funding was raised on 27.02.2007. Their latest investor Wheatley Partners. Their latest round Series C
Safeguard Scientifics
Safeguard Scientifics provides capital and operational support to growth-stage health care and technology companies.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
count Of Exists
Wheatley Partners
Wheatley Partners is a private equity firm focused on technology-related companies.
Sector
Subsector
Location
count Of Investments
count Of Exists
Canaan Partners
Canaan Partners is an early stage venture capital firm.
Sector
Subsector
Location
count Of Investments
count Of Exists
Co-Investors
Investors5
Number of lead investors
Number of investors
Wheatley Partners
Wheatley Partners is a private equity firm focused on technology-related companies.
Sector
Subsector
Location
count Of Investments
count Of Exists
Canaan Partners
Canaan Partners is an early stage venture capital firm.
Sector
Subsector
Location
count Of Investments
count Of Exists
Safeguard Scientifics
Safeguard Scientifics provides capital and operational support to growth-stage health care and technology companies.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
count Of Exists
Gary Kurtzman
Gary Kurtzman has more than 25 years of experience as an entrepreneur, board member, financier and operator. As Managing Director of Healthcare at Safeguard Scientifics (NYSE:SFE), Gary Kurtzman leverages his medical expertise to empower businesses to enhance their products, expand their services, and identify strategic partnership opportunities. Gary Kurtzman has realized value for companies through a series of successful IPOs, M&A and turnaround transactions—most recently Shire’s acquisition of Safeguard’s partner company Advanced BioHealing for $750 million, in cash; and Eli Lilly’s acquisition of Safeguard’s partner company Avid Radiopharmaceuticals for $300 million, up front, with an additional $500 million payout dependent upon the achievement of future regulatory and commercial milestones. Gary Kurtzman’s previous experiences include leadership roles at BioAdvance, Pluvita Corporation, Genovo, Avigen, and Gilead Sciences. Presently, Gary Kurtzman is a lecturer in the Health Care Systems Department at the Wharton School at the University of Pennsylvania where he teaches entrepreneurship in life sciences. In addition, he is also a member of the board at Safeguard’s partner companies Alverix, Crescendo Bioscience, Good Start Genetics, Medivo and PixelOptics.
current job
People
Founders1
David E. Eisenbud
Dr. Eisenbud is the Chief Medical Officer of coda therapeutics .
current job
organization founded
David E. Eisenbud